Identification of Molecular Biomarkers to Stratify Patients With Refractory Asthma



Status:Active, not recruiting
Conditions:Asthma
Therapuetic Areas:Pulmonary / Respiratory Diseases
Healthy:No
Age Range:18 - Any
Updated:4/21/2016
Start Date:January 2012
End Date:June 2016

Use our guide to learn which trials are right for you!

The purpose of this study is to learn more about asthma in people who are not
well-controlled with current asthma medication (refractory asthma). The investigators will
compare data from refractory asthmatic patients here at National Jewish Health to mild
asthmatics subjects and to people without asthma. Study experiments involve looking at
samples from all 3 groups and comparing them at a molecular level. These laboratory
experiments may help identify subtypes of refractory asthmatics that require different
treatments.


Inclusion Criteria:

- Able to receive Informed Consent

- At least 18 years of age

- ICS < 880 mcg (FP equivalents)

- PC20<=16 mg/mL

- No more than 1 oral steroid bursts in previous 12 months

- Less that 3 urgent care visit in previous 12 months

- No deterioration with <=25% decrease in steroids

- No near fatal asthma event

Exclusion Criteria:

- Pregnancy

- Current smoker, smoking within the past year or pack/year history >10 years

- Respiratory infection within past 6 weeks

- Antibiotics within the past 6 weeks

- Active lung disease other than asthma

- Cancer within past 5 years (excluding basal cell skin cancer)

- Active or chronic infection

- Hematological or autoimmune disease

- Unable to safely undergo bronchoscopy as determined by doctor or study doctor
We found this trial at
1
site
1400 Jackson St
Denver, Colorado 80206
(303) 388-4461
National Jewish Health National Jewish Health is known worldwide for treatment of patients with respiratory,...
?
mi
from
Denver, CO
Click here to add this to my saved trials